126 related articles for article (PubMed ID: 11439742)
1. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution.
Günal AI; Duman S; Sen S; Unsal A; Terzioğlu E; Akçiçek F; Basci A
J Nephrol; 2001; 14(3):184-9. PubMed ID: 11439742
[TBL] [Abstract][Full Text] [Related]
2. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
3. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
[TBL] [Abstract][Full Text] [Related]
4. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
5. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?
Duman S; Günal AI; Sen S; Asçi G; Ozkahya M; Terzioglu E; Akçiçek F; Atabay G
Perit Dial Int; 2001; 21(2):219-24. PubMed ID: 11330572
[TBL] [Abstract][Full Text] [Related]
6. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
7. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
Hung KY; Huang JW; Chiang CK; Tsai TJ
Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in rats.
Duman S; Sen S; Sozmen EY; Oreopoulos DG
Int J Artif Organs; 2005 Feb; 28(2):170-6. PubMed ID: 15770605
[TBL] [Abstract][Full Text] [Related]
10. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
[TBL] [Abstract][Full Text] [Related]
12. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucose on TGF-beta 1 expression in peritoneal mesothelial cells.
Wang T; Chen YG; Ye RG; Li SL; Li HQ; Chen YX
Adv Perit Dial; 1995; 11():7-10. PubMed ID: 8534742
[TBL] [Abstract][Full Text] [Related]
14. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
15. [The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].
Dou XR; Yu XQ; Li XY; Chen WF; Hao WK; Jia ZJ; Peng WX; Wang X; Yin PD; Wang WJ; Zheng ZH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2613-8. PubMed ID: 16321321
[TBL] [Abstract][Full Text] [Related]
16. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
[TBL] [Abstract][Full Text] [Related]
17. [Comparision of several different peritoneal fibrosis rat models].
Zhuo L; Liu FY; Peng YM; Liu YH; Liu H; Zhou LH; Xu XQ; Jiang JH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):162-6. PubMed ID: 15898425
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
19. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
20. The TGF-beta-induced gene product, betaig-h3: its biological implications in peritoneal dialysis.
Park SH; Choi SY; Kim MH; Oh EJ; Ryu HM; Kim CD; Kim IS; Kim YL
Nephrol Dial Transplant; 2008 Jan; 23(1):126-35. PubMed ID: 17704110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
